Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Tan, Youwen
NCT05115942: Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.	Completed	3	248	RoW	Hydronidone capsules, F351, The placebo capsules, N	Beijing Continent Pharmaceutical Co, Ltd.	Liver Fibrosis	10/24	10/24
NCT05905172: Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis	Recruiting	3	248	RoW	Hydronidone capsules, F351, The placebo capsules, N	Beijing Continent Pharmaceutical Co, Ltd.	Liver Fibrosis	06/28	10/28
NCT05395416: Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C	Recruiting	2/3	520	RoW	HEC74647PA+HEC110114, Antaitavir Hasophate+Yiqibuvir, Placebo	Sunshine Lake Pharma Co., Ltd.	Chronic HCV Infection	04/23	04/23
NCT04147208: Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection	Completed	2	250	RoW	GLS4, Morphothiadine Mesilate Capsules, RTV, Ritonavir tablet, ETV, Entecavir table	Sunshine Lake Pharma Co., Ltd.	Chronic HBV Infection	06/22	09/23